Euclidean Capital LLC Top Holdings and 13F Report (2025) About Euclidean Capital LLCInvestment ActivityEuclidean Capital LLC has $266.12 million in total holdings as of March 31, 2025.Euclidean Capital LLC owns shares of 11 different stocks, but just 2 companies or ETFs make up 80% of its holdings.Approximately 22.30% of the portfolio was purchased this quarter.About 187.53% of the portfolio was sold this quarter.This quarter, Euclidean Capital LLC has purchased 11 new stocks and bought additional shares in 1 stock.Euclidean Capital LLC sold shares of 1 stock and completely divested from 0 stocks this quarter.Largest Holdings iShares MSCI India ETF $124,846,413Vanguard FTSE All-World ex-US ETF $120,827,683Foghorn Therapeutics $5,744,228ORIC Pharmaceuticals $5,520,908PMV Pharmaceuticals $2,864,131 Largest Purchases this Quarter Vanguard FTSE All-World ex-US ETF 978,450 shares (about $59.35M) Largest Sales this Quarter SPDR S&P 500 ETF Trust 892,150 shares (about $499.06M) Sector Allocation Over TimeMap of 500 Largest Holdings ofEuclidean Capital LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorINDAiShares MSCI India ETF$124,846,4130.0%2,425,14446.9%ETFVEUVanguard FTSE All-World ex-US ETF$120,827,683$59,352,777 ▲96.5%1,991,88445.4%ETFFHTXFoghorn Therapeutics$5,744,2280.0%1,573,7612.2%MedicalORICORIC Pharmaceuticals$5,520,9080.0%989,4102.1%MedicalPMVPPMV Pharmaceuticals$2,864,1310.0%2,627,6431.1%MedicalSPYSPDR S&P 500 ETF Trust$2,295,737$499,059,884 ▼-99.5%4,1040.9%FinanceALECAlector$1,608,6650.0%1,307,8580.6%MedicalSURROZEN INC$1,022,5350.0%87,6960.4%COM NEWRAPTRAPT Therapeutics$802,6370.0%657,8990.3%MedicalTNYATenaya Therapeutics$579,0530.0%1,015,7050.2%MedicalSRZNWSurrozen$5,1250.0%170,8330.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
